About Roy Bilberry

This author has not yet filled in any details.
So far Roy Bilberry has created 3 blog entries.

U.S. approves first marijuana-based drug for seizures

WASHINGTON -- U.S. health regulators on Monday approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use. The Food and Drug Administration (FDA) approved the medication, called Epidiolex, to treat two rare forms of [...]

By | 2018-09-26T02:17:00+00:00 September 26th, 2018|CBD in the News|0 Comments

The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it’ll cost

On a call with investors this week, GW Pharmaceuticals revealed the price of Epidiolex, its newly-approved, marijuana-based drug for rare forms of epilepsy. Designed to treat two rare forms of childhood epilepsy using a marijuana compound called CBD, the drug is the first medication of its kind to get FDA approval. The person leading the company's commercialization efforts [...]

By | 2018-09-26T02:07:22+00:00 September 26th, 2018|CBD in the News|0 Comments

Exclusive: New Report Predicts CBD Market Will Hit $22 Billion by 2022

Looking forward to relaxed hemp regulations, a new analysis estimates that the CBD market could explode — and outpace marijuana For years, experts have predicted that if the cannabis industry expands at its current rate, the American market will reach $20 billion by 2020. But it turns out that one market is spinning off into a [...]

By | 2018-09-14T17:07:25+00:00 September 14th, 2018|CBD in the News|0 Comments



Email:
Mobile:

Contact NexCel Now